// App-Quantinova.ai

21665 : Serum Metabolomic Profiles Predict Coronary Heart Disease in the General Population - The Biomarcare Consortium

Researchers

Presenter

  • Tanja Zeller

Principal Investigators

  • Daniela Brnigen

  • Francisco M. Ojeda

  • Mahir Karakas

  • Giovanni Veronesi

  • Torben Jorgensen

  • Licia Iacoviello

  • Hugh Tunstall-Pedoe

  • Kari Kuulasmaa

  • Veikko Salomaa

  • Stefan Blankenberg

Medical Centers

  • General and Interventional Cardiology, UHZ Hamburg, Hamburg, Germany

  • Rsch Cntr in Epidemiology and Preventive Medicine, Dept of Medicine and Surgery, Univ of Insubria, Insubria, Italy

  • Rsch Cntr for Prevention and Health, Rsch Cntr for Prevention and Health, Copenhagen, Denmark

  • Dept of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy

  • Cardiovascular Epidemiology Unit, Institute of Cardiovascular Rsch, Dundee, United Kingdom

  • National Institute for Health and Welfare, Finland, National Institute for Health and Welfare, Finland, Helsinki, Finland

Locations

  • Germany

  • Italy

  • Denmark

  • United Kingdom

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved